IRIS Accounts Production v24.2.0.383 14600085 Board of Directors 18.1.23 31.3.24 31.3.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh146000852023-01-17146000852024-03-31146000852023-01-182024-03-31146000852023-01-1714600085ns15:EnglandWales2023-01-182024-03-3114600085ns14:PoundSterling2023-01-182024-03-3114600085ns10:Director12023-01-182024-03-3114600085ns10:PrivateLimitedCompanyLtd2023-01-182024-03-3114600085ns10:SmallEntities2023-01-182024-03-3114600085ns10:AuditExempt-NoAccountantsReport2023-01-182024-03-3114600085ns10:SmallCompaniesRegimeForDirectorsReport2023-01-182024-03-3114600085ns10:SmallCompaniesRegimeForAccounts2023-01-182024-03-3114600085ns10:FullAccounts2023-01-182024-03-311460008512023-01-182024-03-3114600085ns10:Director22023-01-182024-03-3114600085ns10:Director32023-01-182024-03-3114600085ns10:Director62023-01-182024-03-3114600085ns10:RegisteredOffice2023-01-182024-03-3114600085ns5:CurrentFinancialInstruments2024-03-3114600085ns5:Non-currentFinancialInstruments2024-03-3114600085ns5:ShareCapital2024-03-3114600085ns5:RetainedEarningsAccumulatedLosses2024-03-3114600085ns5:NetGoodwill2023-01-182024-03-3114600085ns5:IntangibleAssetsOtherThanGoodwill2023-01-182024-03-3114600085ns5:PatentsTrademarksLicencesConcessionsSimilar2023-01-182024-03-3114600085ns5:ComputerSoftware2023-01-182024-03-3114600085ns5:PlantMachinery2023-01-182024-03-3114600085ns5:NetGoodwill2024-03-3114600085ns5:IntangibleAssetsOtherThanGoodwill2024-03-3114600085ns5:PlantMachinery2024-03-3114600085ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-3114600085ns5:HirePurchaseContractsns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-311460008512023-01-182024-03-31
REGISTERED NUMBER: 14600085 (England and Wales)















ALEVERE NUTRITION LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE PERIOD 18 JANUARY 2023 TO 31 MARCH 2024






ALEVERE NUTRITION LIMITED (REGISTERED NUMBER: 14600085)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE PERIOD 18 JANUARY 2023 TO 31 MARCH 2024










Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


ALEVERE NUTRITION LIMITED

COMPANY INFORMATION
FOR THE PERIOD 18 JANUARY 2023 TO 31 MARCH 2024







DIRECTORS: J P McGivern
K Amphlett
N A O'Melia
S Szpitter





REGISTERED OFFICE: The Orchards
Carleton
Carlisle
Cumbria
CA1 3DZ





REGISTERED NUMBER: 14600085 (England and Wales)





ACCOUNTANTS: DJH Bury Limited
The Exchange
5 Bank Street
Bury
Lancashire
BL9 0DN

ALEVERE NUTRITION LIMITED (REGISTERED NUMBER: 14600085)

STATEMENT OF FINANCIAL POSITION
31 MARCH 2024

Notes £   
FIXED ASSETS
Intangible assets 4 115,069
Property, plant and equipment 5 84,994
200,063

CURRENT ASSETS
Inventories 106,546
Debtors 6 226,068
Cash at bank and in hand 6,830
339,444
CREDITORS
Amounts falling due within one year 7 (227,223 )
NET CURRENT ASSETS 112,221
TOTAL ASSETS LESS CURRENT
LIABILITIES

312,284

CREDITORS
Amounts falling due after more than one
year

8

(865,451

)
NET LIABILITIES (553,167 )

CAPITAL AND RESERVES
Called up share capital 1,000
Retained earnings (554,167 )
(553,167 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

ALEVERE NUTRITION LIMITED (REGISTERED NUMBER: 14600085)

STATEMENT OF FINANCIAL POSITION - continued
31 MARCH 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 15 January 2025 and were signed on its behalf by:





J P McGivern - Director


ALEVERE NUTRITION LIMITED (REGISTERED NUMBER: 14600085)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD 18 JANUARY 2023 TO 31 MARCH 2024


1. STATUTORY INFORMATION

Alevere Nutrition Limited is a private company, limited by shares, registered in England and Wales. The company's registered number is 14600085, and registered office address is The Orchards, Carleton, Carlisle, Cumbria, CA1 3DZ.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Going concern
At the statement of financial position, the company had net liabilities of £553,167 and reported a net loss for the year.

Alevere Nutrition Limited was established on 18 January 2023, arising from purchasing the assets of the Silverlink Group Limited and Silverlink Clinic (Newcastle) Limited, which was in liquidation. As a result, there were a number of costs that were borne that bore relation to the previous entities which were absorbed into this year. In addition, the business has restructured its management team which resulted in further one off costs which will not reoccur. The directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Therefore the directors continue to adopt the going concern basis in preparing the financial statements.

Included within creditors falling due after more than one year is an amount due to a shareholder, JKA Investments Limited, of £865,451. The shareholder has indicated their continued support and will not seek repayment of the balance to the detriment of the company.

Significant judgements and estimates
In the application of the company's accounting policies, the directors are required to make estimates and judgements. The estimates are based on historical experience and other relevant factors. Actual results may differ from these estimates.

The estimates are continually evaluated. Revisions to accounting estimates are recognised in the period in which the estimate is revised.

The estimates and assumptions which have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities are outlined below.

Estimating the useful economic life of an asset and the anticipated residual value are considered the key judgement in calculating an appropriate depreciation charge.

In categorising leases as finance or operating leases, the directors make judgements as to whether significant risks and rewards of ownership have transferred to the company as lessee.

ALEVERE NUTRITION LIMITED (REGISTERED NUMBER: 14600085)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 18 JANUARY 2023 TO 31 MARCH 2024


2. ACCOUNTING POLICIES - continued

Revenue
Revenue comprises the aggregate of the fair value of the sale of goods and services provided, net of value-added tax, rebates and discounts.

Revenue from the sale of goods is recognised when the company has delivered products to the customer, the customer has accepted the products and collectability of the related receivables is fairly stated.

Service revenues are recognised as those services are provided to customers.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2023, is being amortised evenly over its estimated useful life of five years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Other intangible assets are being amortised evenly over their estimated useful life of five years.

Website is being amortised evenly over its estimated useful life of five years.

Property, plant and equipment
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 33% on cost and 20% on cost

The residual values, estimated useful lives and depreciation method of property, plant and equipment are reviewed, and adjusted as appropriate, at each statement of financial position date. The effects of any revision are recognised in the income statement when the change arises.

Inventory
Inventories are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Cost is the direct cost of goods purchased.

Net realisable value is the estimated selling price less costs to complete and sell.

Financial instruments
The company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable, loans from banks and other third parties and loans to related parties.

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the income statement.

Basic financial liabilities are initially measured at transaction price and subsequently measured at amortised cost, being the transaction price less any amounts settled.


ALEVERE NUTRITION LIMITED (REGISTERED NUMBER: 14600085)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 18 JANUARY 2023 TO 31 MARCH 2024


2. ACCOUNTING POLICIES - continued
Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the statement of financial position date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the statement of financial position. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 32 .

ALEVERE NUTRITION LIMITED (REGISTERED NUMBER: 14600085)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 18 JANUARY 2023 TO 31 MARCH 2024


4. INTANGIBLE FIXED ASSETS
Other
intangible
Goodwill assets Totals
£    £    £   
COST
Additions 60,857 77,685 138,542
At 31 March 2024 60,857 77,685 138,542
AMORTISATION
Charge for period 5,348 18,125 23,473
At 31 March 2024 5,348 18,125 23,473
NET BOOK VALUE
At 31 March 2024 55,509 59,560 115,069

5. PROPERTY, PLANT AND EQUIPMENT
Plant and
machinery
etc
£   
COST
Additions 149,501
Disposals (36,000 )
At 31 March 2024 113,501
DEPRECIATION
Charge for period 36,447
Eliminated on disposal (7,940 )
At 31 March 2024 28,507
NET BOOK VALUE
At 31 March 2024 84,994

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Trade debtors 18,882
Other debtors 207,186
226,068

ALEVERE NUTRITION LIMITED (REGISTERED NUMBER: 14600085)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 18 JANUARY 2023 TO 31 MARCH 2024


7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Hire purchase contracts (see note 9) 9,267
Trade creditors 165,123
Taxation and social security 9,170
Other creditors 43,663
227,223

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
£   
Amounts owed to participating interests 865,451

9. LEASING AGREEMENTS

Minimum lease payments fall due as follows:

Hire
purchase
contracts
£   
Net obligations repayable:
Within one year 9,267

Non-cancellable
operating leases
2024
£
Within one year 55,300
Between one and five years 125,733
181,033

10. SECURED DEBTS

The following secured debts are included within creditors:

£   
Hire purchase contracts 9,267

Hire purchase contracts are secured against the assets to which they relate.

11. RELATED PARTY DISCLOSURES

Included within creditors falling due after more than one year is an amount due to a shareholder, JKA Investments Limited, of £865,451. This amount attracts interest at a rate of 10% per annum, is unsecured, and is repayable upon demand.

ALEVERE NUTRITION LIMITED (REGISTERED NUMBER: 14600085)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 18 JANUARY 2023 TO 31 MARCH 2024


12. POST BALANCE SHEET EVENTS

On 31 December 2024, Alevere Nutrition Limited disposed of its six clinics. This will allow the business to focus on the distribution side of the business and allow for expansion of products to offer our portfolio of partner clinics. It will also enable growth into other areas.